Consumer Info “Usefulness” Needs Further Definition, Pharmacy Groups Say
Executive Summary
FDA should convene an expert panel to refine the definition of "usefulness" for written consumer prescription drug information, the American Society of Health-System Pharmacists recommended
You may also be interested in...
Useful Consumer Drug Info Implementation May Be Delayed By FDA Guidance
FDA's release of final guidance on consumer medication information could prevent companies from meeting legislatively mandated compliance targets regarding useful written patient information
Useful Consumer Drug Info Implementation May Be Delayed By FDA Guidance
FDA's release of final guidance on consumer medication information could prevent companies from meeting legislatively mandated compliance targets regarding useful written patient information
FDA Should Create Oversight Body For Consumer Rx Information, Cmte Says
FDA should create an oversight group with enforcement authority to ensure that privately distributed consumer drug information complies with "usefulness" criteria, FDA's Drug Safety & Risk Management Advisory Committee recommended July 17